World

X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)

"This submission was the culmination of several years of development activities and the establishment of a Good Manufacturing Practices (GMP) manufacturing...

 April 19, 2024 | News

Exyte Strengthens Global Presence with Kinetics Group Acquisition

Kinetics is a globally leading provider of installation services and equipment  Company serves high-tech industries such as semiconductor, biopharm...

 April 17, 2024 | News

Serum Institute of India and Univercells Unite to Make Personalized Cancer Treatments Widely Available

 Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells, a Belgian biotech innovator,...

 April 12, 2024 | News

Grindeks Expands Global Footprint with New Subsidiaries and Innovative Product Pipeline

In a strategic move to broaden its international market presence, Grindeks has successfully established 28 subsidiaries across Eu...

 April 03, 2024 | News

Abbott's Bedside Blood Test Transforms Concussion Assessment

Abbott's i-STAT TBI cartridge has received clearance from the U.S. Food and Drug Administration (FDA) to be used with whole blood, enabling doctors to asse...

 April 02, 2024 | News

Bayer AG Partners with Thermo Fisher for Breakthrough in Cancer Treatment Diagnostics

Development of next-generation sequencing companion diagnostics (CDx) Goal is to help increase patient access to Bayer’s precision cancer therapie...

 March 20, 2024 | News

AstraZeneca Acquires Fusion Pharmaceuticals in a $2 Billion Upfront Deal

AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-gene...

 March 19, 2024 | News

Almirall and Eloxx Pharmaceuticals Forge Exclusive Global License Agreement for Rare Disease Treatment ZKN-013

Almirall, S.A. (BME:ALM), a global biopharmaceutical company, and Eloxx Pharmaceuticals, Inc. (OTC: ELOX), a clinical-stage biopharmaceutical innovator, ha...

 March 14, 2024 | News

Glen Godresse Charts a New Course for Menarini Asia-Pacific: A Vision of Growth Through Patient-Centric Innovation

BioPharma APAC sits down with Glen Godresse, the newly appointed Chief Executive Officer of Menarini Asia-Pacific, to discuss his strategic vision for the ...

 March 13, 2024 | Interview

GenScript Surges with 34.2% Revenue Growth in 2023, Sherry Shao Highlights Innovation and Team Effort

R&D Innovation to Lead the Future, Deepening Customer Value Creation Sustained High Revenue Growth: GenScript Group's five-year CAGR stands at ...

 March 13, 2024 | News

TransThera Launches Global Phase 3 Trial for Cholangiocarcinoma in EU, Receives Orphan Drug Status for Tinengotinib from EMA

TransThera, a clinical-stage biopharmaceutical company dedicated to innovating differentiated drugs globally, today announced that the randomized, controll...

 March 11, 2024 | News

Merck Opens new € 20 Million Distribution Center in Brazil

New site in Cajamar, São Paulo has 2.5 times more storage capacity than previous space in Cotia, São Paulo 13,000 square-meters space for ...

 March 04, 2024 | News

Waters Launches HPLC/UPLC-MALS Integration Software for Advanced Biologic Drug Characterization

At Pittcon 2024, Waters Corporation (NYSE:WAT) unveiled the HPLC CONNECT software, a comprehensive software solution designed to facilitate seamless digita...

 February 29, 2024 | News

Enveric Biosciences Divests Cancer-Targeting Cannabinoid IP to Focus on Mental Health Therapeutics

  Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...

 February 26, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close